関連する実験動画

Updated: May 4, 2026

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on: July 29, 2010

潰瘍性大腸炎の分子シグネチャーとしての持続的な遺伝子活性化,大腸がんへの進行,大腸がんへの進行

Yuxiao Ji¹, Pengchong Li¹, Yuqi Liu²

¹Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Disease, Beijing Digestive Disease Center, State Key Laboratory of Digestive Health, 95 Yong'an Road, Xicheng District, Beijing, 100050, China.

Digestive diseases and sciences

|February 19, 2026

まとめ

7つの遺伝子は,潰瘍性大腸炎 (UC) と大腸炎関連結腸直腸がん (CAC) の進行において一貫して上昇しています. 中性粒子のPD-L1の上昇は,免疫抑制を示唆し,早期がん検出と治療のための潜在的なバイオマーカーを強調しています.

科学分野:

胃腸内科胃腸内科
腫瘍学腫瘍学
免疫学免疫学とは

背景:

潰瘍性大腸炎 (UC) は,結腸内皮質の損傷を含み,時と共に悪性変異のリスクを高めます.
UCにおける慢性炎症と結腸直腸がん (CAC) の発症を結びつけるメカニズムは完全に理解されていません.

研究の目的:

健康な対照群 (HC) からUC,その後CACへの移行に寄与する遺伝子を特定する.
UCに関連する腫瘍発生における中性粒子の役割と免疫経路を調査する.

主な方法:

遺伝子発現オムニバス (GEO) データセットのバイオインフォマティック分析により,差異的に発現する遺伝子を特定します.
機能的濃縮と免疫浸透分析.
インターフェロン-ガンマ (IFN-γ) と腫瘍死滅因子-α (TNF-α) で刺激された中性粒子のプログラム死亡リガンド1 (PD-L1) 発現を評価するインビトロ実験.

主要な成果:

7つの遺伝子 (S100A8,IL33,MGP,MMP3,CFI,CLU,CLEC4E) は,HCからUCへの移行とUCからCACへの移行の両方でアップレギュレーションされました.
これらの遺伝子は中性粒子を伴い,IFN-γ,TNF-α,酸化性リン酸化を含む経路と関連しています.
IFN-γとTNF-αの刺激により,中性粒子のPD-L1発現が著しく増加しました.

結論:

7つの遺伝子はUCとCACの進行中に持続的にアップレギュレーションされ,中性粒子を影響し,炎症/腫瘍起源の経路に影響を与えます.
中性粒子のPD-L1の増加は,中性粒子の媒介による免疫抑制がCAC進行における役割を示唆しています.
これらの遺伝子とPD-L1は,UC関連の癌の早期介入のための潜在的な分子マーカーと治療標的を表しています.

キーワード:

バイオインフォマティクス分析大腸炎に関連した結腸直腸がん.遺伝子遺伝子遺伝子中性粒子は中性粒子を潰瘍性大腸炎 (Ulcerative colitis) とは,潰瘍性大腸炎 (Ulcerative colitis) とは,潰瘍性大腸炎 (Ulcerative colitis) とは,潰瘍性大腸炎 (Ulcerative colitis) とは,潰瘍性大腸炎 (Ulcerative colitis) とは,潰瘍性大腸炎 (Ulcerative

さらに関連する動画

In vitro Organoid Culture of Primary Mouse Colon Tumors

In vitro Organoid Culture of Primary Mouse Colon Tumors

Published on: May 17, 2013

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

関連する概念動画

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Cancer-Critical Genes I: Proto-oncogenes

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Inflammatory Bowel Disease II: Ulcerative Colitis

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal...

Inflammatory Bowel Disease III: Crohn's Disease

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...